当前位置: X-MOL 学术J. Invest. Dermatol. › 论文详情
Involvement of p53 acetylation in growth suppression of Cutaneous T-cell lymphomas induced by HDAC inhibition.
Journal of Investigative Dermatology ( IF 6.290 ) Pub Date : 2020-02-28 , DOI: 10.1016/j.jid.2019.12.041
Xiaoxuan Yu,Hui Li,Mengyuan Zhu,Po Hu,Xiao Liu,Yingjie Qing,Xiangyuan Wang,Hongzheng Wang,Zhanyu Wang,Jingyan Xu,Renxiang Tan,Qinglong Guo,Hui Hui

CTCLs represent a rare form of non-Hodgkin's lymphomas characterized by an accumulation of malignant CD4+ T cells in the skin. TP53 genetic alteration is one of the most prevalent genetic abnormalities in CTCLs. Therefore, it is a promising target for innovative therapeutic approaches. We found that p53 could physically interact with HDAC-1/8 and subsequently was deacetylated to lose its function in CTCL-cells, and the p53 downstream apoptosis-associated genes were repressed. Thus, the anti-CTCL activity displayed by HDAC inhibitors depends on the p53 status. However, recent studies have shown that HDAC inhibitors could induce a wide variety of drug-resistant characteristic in cancer cells by regulating ABC transporters. Moreover, we discovered that Baicalein, a natural product, exhibited inhibitory effect on HDAC-1/8. Though the inhibition of HDAC-1 was mild, Baicalein could induce the degradation of HDAC-1 via ubiquitin proteasome pathway, thereby markedly up-regulating the acetylation of Histone H3 without promoting ABC transporter genes expression. In terms of the mechanism, Baicalein showed a better growth inhibition than traditional HDAC inhibitors in CTCLs. This study indicates a special mechanism of HDAC-1/8 and p53 in T-cell lymphoma cells, and provides a potential and safe natural HDAC inhibitor for the treatment of CTCLs.
更新日期:2020-03-02

 

全部期刊列表>>
如何通过Nature平台传播科研成果
跟Nature、Science文章学绘图
隐藏1h前已浏览文章
课题组网站
新版X-MOL期刊搜索和高级搜索功能介绍
中洪博元
ACS材料视界
x-mol收录
南开大学
朱守非
廖良生
南方科技大学
西湖大学
伊利诺伊大学香槟分校
徐明华
中山大学化学工程与技术学院
试剂库存
天合科研
down
wechat
bug